Trial Profile

A phase 1 study of rodatristat ethyl (Rodatristat) in healthy volunteers

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 31 Oct 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Rodatristat ethyl (Primary)
Indications Pulmonary arterial hypertension
Focus Adverse reactions; Pharmacokinetics
Acronyms RVT-1201-100

Most Recent Events

22 Oct 2019 According to an Altavant Sciences media release, data from this trial was presented at the American College of Chest Physicians CHEST Annual Meeting 2019 in New Orleans.
22 Oct 2019 Results presented in an Altavant Sciences media release.
18 Oct 2019 According to an Altavant Sciences media release, data from this study will be presented at the American College of Chest Physician's annual CHEST 2019 meeting.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com